Tuomas Paana - Search Results

Year	Number of Results
2009	1
2014	1
2015	2
2016	5
2017	3
2019	2
2021	1
2022	0

1

Minor troponin T elevation and mortality in patients with atrial fibrillation presenting to the emergency department.

Paana T, Jaakkola S, Biancari F, Nuotio I, Vasankari T, Kiviniemi TO, Airaksinen KEJ. Paana T, et al. Eur J Clin Invest. 2021 Nov;51(11):e13590. doi: 10.1111/eci.13590. Epub 2021 May 18. Eur J Clin Invest. 2021. PMID: 34002383

2

Renal sympathetic denervation for treatment of patients with atrial fibrillation: Reappraisal of the available evidence.

Nammas W, Airaksinen JK, Paana T, Karjalainen PP. Nammas W, et al. Among authors: paana t. Heart Rhythm. 2016 Dec;13(12):2388-2394. doi: 10.1016/j.hrthm.2016.08.043. Epub 2016 Aug 30. Heart Rhythm. 2016. PMID: 27590432 Review.

3

Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence.

Nammas W, Koistinen J, Paana T, Karjalainen PP. Nammas W, et al. Among authors: paana t. Ann Med. 2017 Aug;49(5):384-395. doi: 10.1080/07853890.2017.1282168. Epub 2017 Feb 10. Ann Med. 2017. PMID: 28276870 Review.

4

Cardiac troponin elevations in marathon runners. Role of coronary atherosclerosis and skeletal muscle injury. The MaraCat Study.

Paana T, Jaakkola S, Bamberg K, Saraste A, Tuunainen E, Wittfooth S, Kallio P, Heinonen OJ, Knuuti J, Pettersson K, Airaksinen KEJ. Paana T, et al. Int J Cardiol. 2019 Nov 15;295:25-28. doi: 10.1016/j.ijcard.2019.08.019. Epub 2019 Aug 7. Int J Cardiol. 2019. PMID: 31420104 Free article.

5

Personalized ADP-receptor inhibition strategy and outcomes following primary PCI for STEMI (PASTOR study).

Mikkelsson J, Paana T, Lepantalo A, Karjalainen PP. Mikkelsson J, et al. Among authors: paana t. Int J Cardiol. 2016 Jan 1;202:463-6. doi: 10.1016/j.ijcard.2015.09.074. Epub 2015 Sep 25. Int J Cardiol. 2016. PMID: 26436674

6

Transcatheter leadless pacemaker implantation in a patient with a transvenous dual-chamber pacemaker already in place.

Karjalainen PP, Nammas W, Paana T. Karjalainen PP, et al. Among authors: paana t. J Electrocardiol. 2016 Jul-Aug;49(4):554-6. doi: 10.1016/j.jelectrocard.2016.05.002. Epub 2016 May 13. J Electrocardiol. 2016. PMID: 27323664

7

Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.

Karjalainen P, Paana T, Ylitalo A, Sia J, Nammas W. Karjalainen P, et al. Among authors: paana t. Acta Radiol. 2017 Sep;58(9):1077-1084. doi: 10.1177/0284185116683573. Epub 2016 Dec 19. Acta Radiol. 2017. PMID: 28273737 Clinical Trial.

8

Neointimal Healing Evaluated by Optical Coherence Tomography after Drug-Eluting Absorbable Metal Scaffold Implantation in de novo Native Coronary Lesions: Rationale and Design of the Magmaris-OCT Study.

Karjalainen P, Paana T, Sia J, Nammas W. Karjalainen P, et al. Among authors: paana t. Cardiology. 2017;137(4):225-230. doi: 10.1159/000468979. Epub 2017 May 4. Cardiology. 2017. PMID: 28467998

9

Etiology of Minor Troponin Elevations in Patients with Atrial Fibrillation at Emergency Department-Tropo-AF Study.

Jaakkola S, Paana T, Nuotio I, Kiviniemi TO, Pouru JP, Porela P, Biancari F, Airaksinen KEJ. Jaakkola S, et al. Among authors: paana t. J Clin Med. 2019 Nov 14;8(11):1963. doi: 10.3390/jcm8111963. J Clin Med. 2019. PMID: 31739414 Free PMC article.

10

Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study.

Karjalainen PP, Mikkelsson J, Paana T, Nammas W. Karjalainen PP, et al. Among authors: paana t. Catheter Cardiovasc Interv. 2016 Mar;87(4):E122-7. doi: 10.1002/ccd.26104. Epub 2015 Aug 26. Catheter Cardiovasc Interv. 2016. PMID: 26308878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results